Pharmacogenomics, or or how to cut the prices of pharmaceutical R&D

被引：0

作者：

Amir-Aslani, A

机构：

来源：

BIOFUTUR | 2006年 / 262期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：45 / 47

页数：3

共 50 条

[41] An approach to scientific computing in pharmaceutical R&D
Sandler, E
PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6: MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING, 1997, 19 : 2668 - 2669
[42] Green chemistry in pharmaceutical R&D in 2016
Shuster, Leanna
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[43] Virtual pharmaceutical R&D: a strategy for the millennium?
Love, B
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (03): : 89 - 90
[44] Electrochemistry for Detection and Reaction in Pharmaceutical R&D
Eysberg, Martin
LC GC EUROPE, 2017, 30 (10) : 543 - 544
[45] Management for R&D in Pharmaceutical Supply Chains
Huang Yin
Li Xiamiao
Liu Dapeng
MOT2009: PROCEEDINGS OF ZHENGZHOU CONFERENCE ON MANAGEMENT OF TECHNOLOGY, VOLS I AND II, 2009, : 638 - 644
[46] The Dynamics of Pharmaceutical Regulation and R&D Investments
Levaggi, Rosella
Moretto, Michele
Pertile, Paolo
JOURNAL OF PUBLIC ECONOMIC THEORY, 2017, 19 (01) : 121 - 141
[47] Encouraging an Environment for Pharmaceutical R&D in China
Donglei Mao
Qiang Zheng
Journal of Pharmaceutical Innovation, 2009, 4 : 152 - 154
[48] Electrochemistry for Detection and Reaction in Pharmaceutical R&D
Eysberg, Martin
LC GC NORTH AMERICA, 2017, 35 (10) : 754 - 755
[49] Overview of DOV Pharmaceutical R&D development
不详
DRUG NEWS & PERSPECTIVES, 2002, 15 (06) : 332 - 332
[50] Troublesome Signs for Bio/Pharmaceutical R&D
Miller, Jim
BIOPHARM INTERNATIONAL, 2011, 24 (12) : 18 - +

← 1 2 3 4 5 →